Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02275754 · ClinicalTrials.gov registry record · NA

Redes III Patient Navigator Qol Study

A NA study of Breast Cancer and Prostate Cancer, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
NA
Development phase
300
Enrollment target
2
Study locations

NCT02275754: Completed NA study of Breast Cancer and Prostate Cancer, sponsored by The University of Texas Health Science Center at San Antonio.

NCT02275754 is a NA study of Breast Cancer and Prostate Cancer that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 300 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02275754, a NA study of Breast Cancer and Prostate Cancer, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
2
Study locations

Study Summary

This proposed 5-year Redes En Acción research study involves a mixed-methods approach that occurs in two phases across two distinct and diverse HL communities. The RCT involves a 2 X 4 randomized repeated measures design with experimental condition (combined patient navigation \[PN\] over 3 months with access to LCNS PN services\[PNLCNS\] vs. a PN only condition) as the between-groups factor, and time-point (baseline/pre-randomization \[T1\]; post-PNLCNS \[about 3-months post-T1; T2\], and about 6- \[T3\] and about 12-months \[T4\] follow-up post-T2) as the within-groups factor; total follow-up is 15 months. The investigators will compare the effects of the PNLCNS and PN only conditions on QOL and treatment follow-up compliance in 300 (after attrition; n=100, Chicago and n=100, San Antonio) breast, colorectal and prostate HL cancer survivors with no evidence of metastatic disease.

Primary Outcome

The Functional Assessment of Cancer Therapy-General (FACT-G) will be administered to evaluate general domains of QOL. The FACT-G, now in its fourth revision, is one of the most widely used instruments to assess overall adjustment to cancer treatment and survivorship. It is a 27-item self-report questionnaire that takes less than 15 minutes to administer. The FACT-G assesses QOL in four domains of well-being: physical, social/family, emotional and functional well-being. Patients are asked to indi

Interventions

  • BEHAVIORAL PN+LCNC
  • BEHAVIORAL PN Only

Study Locations (2)

Illinois

  • Northwestern University - Chicago

Texas

  • The University of Texas Health Science Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2010-11
Est. Completion 2017-12-31
Phase NA

What the finished NCT02275754 record still lists

NCT02275754 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower).

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which PN+LCNC is the first listed.

NCT02275754 reports a single indexed study location in Illinois, Texas.

Frequently Asked Questions

What is clinical trial NCT02275754 about?

NCT02275754 is a clinical study titled "Redes III Patient Navigator Qol Study". This proposed 5-year Redes En Acción research study involves a mixed-methods approach that occurs in two phases across two distinct and diverse HL communities. The RCT involves a 2 X 4 randomized repeated measures design with experimental condition (combined patient navigation \[PN\] over 3 months w...

What is the current status of trial NCT02275754?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2010-11. Estimated completion is 2017-12-31.

What conditions does trial NCT02275754 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Colorectal Cancer.

What interventions are being tested in trial NCT02275754?

The interventions under investigation include: PN+LCNC (BEHAVIORAL), PN Only (BEHAVIORAL).

Who is sponsoring clinical trial NCT02275754?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02275754 being conducted?

This trial has 2 study locations across Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02275754's enrollment target sits among peer trials

300 277th of 1224 higher than 938 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02275754, the US trial registry maintained by the National Library of Medicine. NCT02275754 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.